Nurse Practitioner · Boston, MA
NPI
1982150850
Since 2016
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
55 Fruit St, Wang 5 Gastroenterology
Boston, MA, 02114
Phone (617) 724-6038
Groups this clinician bills Medicare through
Medicare paid, 2024
$32K
308 services
Medicare patients, 2024
163
Average age 68
Drug cost, 2024
$471K
767 prescriptions
Company payments, 2024
$132
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Samantha Calabrese was code 99215 (office e&m - established), 142 times for 86 patients. In total Samantha Calabrese billed 308 services in 5 codes, and Medicare paid $32K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 142 | 86 | $124.67 | $18K |
| 99214 Office E&M - Established | Office | 68 | 57 | $84.86 | $5,770 |
| 99215 Office E&M - Established | Facility | 62 | 47 | $97.08 | $6,019 |
| 99443 Telephone Services | Facility | 15 | 14 | $68.97 | $1,035 |
By year: 2022 $12K for 155 services; 2023 $21K for 264 services; 2024 $32K for 308 services.
Medicare prescription drug claims, 2024
In 2024, the drug Samantha Calabrese prescribed most often to Medicare patients was Motegrity (Prucalopride Succinate), with 110 prescriptions and refills. In total Samantha Calabrese wrote 767 Medicare prescriptions that cost $471K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Motegrity Prucalopride Succinate | 110 | 237 | 34 | $122K |
| Gabapentin Generic | 72 | 114 | 17 | $657 |
| Omeprazole Generic | 62 | 164 | 24 | $960 |
| Linzess Linaclotide | 51 | 89 | 16 | $49K |
| Pyridostigmine Bromide Generic | 40 | 80 | 12 | $1,482 |
| Nortriptyline Hcl Generic | 38 | 90 | Under 11 | $530 |
| Famotidine Generic | 35 | 99 | 15 | $686 |
| Ibsrela Tenapanor Hcl | 28 | 44 | Under 11 | $71K |
| Buspirone Hcl Generic | 21 | 33 | Under 11 | $206 |
| Pantoprazole Sodium Generic | 20 | 54 | Under 11 | $434 |
| Creon Lipase/Protease/Amylase | 19 | 24 | Under 11 | $71K |
| Trulance Plecanatide | 16 | 36 | Under 11 | $19K |
| Aprepitant Generic | 16 | 16 | Under 11 | $13K |
| Colesevelam Hcl Generic | 15 | 26 | Under 11 | $2,136 |
| Esomeprazole Magnesium Generic | 15 | 39 | Under 11 | $3,009 |
Brand drugs: 278 claims; generic drugs: 489 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Samantha Calabrese $132 ($132 in general payments such as food, travel and fees) from 1 company. The largest payer was Phathom Pharmaceuticals, Inc. with $132.
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. PHAT | 1 | $132 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.